ArticleJournal of thoracic disease2018

Consolidation of immunotherapy becomes new standard of care in unresectable stage III non-small cell lung cancer.

Myung-Ju AhnPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.